FISHER & PAYKEL HEAL

FPH
End-of-day quote. End-of-day quote  - 06/18
30.77NZD -0.42%
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: March 2021 2022
Net sales1 1 9711 662
EBITDA1 786581
Operating profit (EBIT)1 712489
Operating Margin 36,1%29,4%
Pre-Tax Profit (EBT)1 718495
Net income1 524371
Net margin 26,6%22,3%
EPS2 0,900,63
Dividend per Share2 0,380,39
Last update 05/26/202106/01/2021
1 NZD in Million
2 NZD
Estimates
Finances - Leverage
Fiscal Period: March 2021 2022
Net Debt1 --
Net Cash position1 303268
Leverage (Debt / EBITDA) -0,39x-0,46x
Free Cash Flow1 441314
ROE (Net Profit / Equities) 42,0%22,9%
Shareholders' equity1 1 2471 618
ROA (Net Profit / Asset) 29,9%15,9%
Assets1 1 7552 342
Book Value Per Share2 2,642,86
Cash Flow per Share2 1,080,88
Capex1 185220
Capex / Sales 9,37%13,3%
Last update 05/26/202106/01/2021
1 NZD in Million
2 NZD
Estimates
Balance Sheet Analysis
Financial Ratios
Size 2022e 2023e
Capitalization 17 734 M NZD -
Entreprise Value (EV) 17 466 M NZD 17 382 M NZD
Valuation 2022e 2023e
P/E ratio (Price / EPS) 49,2x 42,6x
Capitalization / Revenue 10,7x 9,77x
EV / Revenue 10,5x 9,62x
EV / EBITDA 30,1x 26,8x
Yield (DPS / Price) 1,27% 1,48%
Price to book (Price / BVPS) 10,8x 9,96x
Profitability 2022e 2023e
Operating Margin (EBIT / Sales) 29,4% 30,5%
Operating Leverage (Delta EBIT / Delta Sales) -2,00x 1,42x
Net Margin (Net Profit / Revenue) 22,3% 23,2%
ROA (Net Profit / Asset) 15,9% 23,1%
ROE (Net Profit / Equities) 22,9% 24,1%
Rate of Dividend 62,7% 63,1%
Balance Sheet Analysis 2022e 2023e
CAPEX / Sales   13,3% 9,08%
Cash Flow / Sales 30,4% 27,9%
Capital Intensity (Assets / Sales) 1,41x 1,01x
Financial Leverage (Net Debt / EBITDA) - -
Price Earning Ratio
EPS & Dividend